Hypertension Drugs Companies
Hypertension, or high blood pressure, is a common medical condition that often requires ongoing management with antihypertensive medications.
Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Latest Middle-East and Africa Hypertension Drugs Companies Update
Pfizer partners with local distributors in Egypt and Morocco: July 2023, Pfizer announced partnerships with local distributors in Egypt and Morocco to improve access to its portfolio of antihypertensive medications, including Accuretic (lisinopril/ hydrochlorothiazide) and Zestril (lisinopril).
Novartis launches Sandoz Generics hypertension portfolio in Nigeria: June 2023, Novartis launched its Sandoz Generics portfolio of hypertension medications in Nigeria, offering affordable options for patients with limited access to branded drugs.
Sanofi expands access to Entresto (sacubitril/valsartan) in South Africa: May 2023, Sanofi secured expanded access to Entresto, a first-line treatment for heart failure with preserved ejection fraction (HFpEF), in South Africa through private insurance coverage.
List of Middle-East and Africa Hypertension Drugs Key Companies in the Market
- Abbott (US)
- Johnson & Johnson Services Inc. (US)
- Novartis (Switzerland)
- GlaxoSmithKline plc.(UK)
- AstraZeneca (UK)
- Bayer AG (Germany)
- Pfizer Inc.(US)
- Merck & Co. Inc. (US)
- Sanofi (France)
- Hoffmann-La Roche Ltd (Switzerland)
- Gilead (US)
Hypertension Drugs Market Highlights:
Hypertension Drugs Market Highlights:
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
